Does the Prulifloxacin ECG Study Prove Cardiac Safety of the Drug?

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.1, 2010-01, pp. : 1-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prulifloxacin ECG Study

By > Dionisio Paolo

Clinical Drug Investigation, Vol. 30, Iss. 4, 2010-04 ,pp. : 275-277

Adis International

Access to resources Recommend Favorite

Effects of Prulifloxacin on Cardiac Repolarization in Healthy Subjects: A Randomized, Crossover, Double-Blind versus Placebo, Moxifloxacin-Controlled Study

By > > Dionisio Paolo

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 5-14

Adis International

Access to resources Recommend Favorite

Prulifloxacin

By Susan J. Keam Caroline M. Perry

Drugs, Vol. 64, Iss. 19, 2004-01 ,pp. : 2221-2234

Adis International

Access to resources Recommend Favorite

Prulifloxacin: in vitro (HERG current) and in vivo (conscious dog) assessment of cardiac risk

By Lacroix P. Crumb W.J. Durando L. Ciottoli G.B.

European Journal of Pharmacology, Vol. 477, Iss. 1, 2003-09 ,pp. : 69-72

Elsevier

Access to resources Recommend Favorite

Automated Assessment of Cardiac Autonomic Function by Means of Deceleration Capacity from Noisy, Nonstationary ECG Signals: Validation Study

By Eick Christian Rizas Konstantinos D. Zuern Christine S. Bauer Axel

Annals of Noninvasive Electrocardiology, Vol. 19, Iss. 2, 2014-03 ,pp. : 122-128

Blackwell Publishing

Access to resources Recommend Favorite